Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Just saw this and had to share - Hikma Pharmaceuticals issued a recall on one of their Acetaminophen Injection batches back in July, and it's a pretty serious mix-up. Apparently lot 24070381 (manufactured March 2024, expired September 2025) had the wrong drug inside the bag - Dexmedetomidine HCL was mislabeled as Acetaminophen. If someone didn't catch that and actually administered it, we're talking potential sedation, low heart rate, blood pressure issues, or worse.
They've already had one reported adverse event from this. The FDA recall was extended to consumer/user level, so if you work in any medical facility, you'd want to check your inventory for that lot number. Hikma is asking people to send it back to Inmar Rx Solutions. Honestly this kind of labeling error in pharmaceuticals is the kind of thing that keeps you up at night - one mistake and it could have been catastrophic for a patient. Wild that this happened in 2024 and we're still seeing recalls being extended into 2026.